| Q24651973 | A new equation to estimate glomerular filtration rate |
| Q49057342 | A validated LC-MS/MS method for the quantitative measurement of creatinine as an endogenous biomarker in human plasma |
| Q33846660 | Characterizing pre-dialysis care in the era of eGFR reporting: a cohort study |
| Q51849496 | Chronic kidney disease definition and classification: no need for a rush to judgment. |
| Q37374174 | Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations |
| Q49041943 | Cystatin C, creatinine, estimated glomerular filtration, and long-term mortality in stroke patients |
| Q93038303 | Diagnostic performance of the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation at estimating glomerular filtration rate in adults with diabetes mellitus: a systematic review and meta-analysis protocol |
| Q37728653 | Early recognition and prevention of chronic kidney disease |
| Q48126541 | Effect of levosimendan on estimated glomerular filtration rate in hospitalized patients with decompensated heart failure and renal dysfunction |
| Q87353510 | Effect of lipo-prostaglandin E1 on cystatin C, β2-microglobulin, and estimated glomerular filtration rate in patients with decompensated heart failure and renal dysfunction: a single-center, nonrandomized controlled study |
| Q37260201 | Estimated GFR reporting influences recommendations for dialysis initiation |
| Q33756494 | Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions |
| Q84879460 | Impact of reporting estimated glomerular filtration rate: it's not just about us |
| Q34334349 | Implementation of automated reporting of estimated glomerular filtration rate among Veterans Affairs laboratories: a retrospective study |
| Q33684032 | Imprecision of creatinine-based GFR estimates in uninephric kidney donors |
| Q108126970 | Machine Learning Prediction of Biomarkers from SNPs and of Disease Risk from Biomarkers in the UK Biobank |
| Q92893817 | Noninvasive monitoring of chronic kidney disease using pH and perfusion imaging |
| Q36687721 | Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals |
| Q33961225 | Performance of creatinine-based GFR estimating equations in solid-organ transplant recipients |
| Q43986995 | Performance of the creatinine-based and the cystatin C-based glomerular filtration rate (GFR) estimating equations in a heterogenous sample of patients referred for nuclear GFR testing |
| Q38152329 | Pharmacokinetic of antiepileptic drugs in patients with hepatic or renal impairment |
| Q34008613 | Predialysis nephrology care of older patients approaching end-stage renal disease |
| Q36972382 | Progress and promise in the management of chronic kidney disease |
| Q45815953 | Regulatory perspectives on designing pharmacokinetic studies and optimizing labeling recommendations for patients with chronic kidney disease |
| Q24633404 | Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: the Atherosclerosis Risk in Communities (ARIC) Study |
| Q36334563 | Serum concentration of cystatin C and risk of end-stage renal disease in diabetes |
| Q46851869 | The assessment of GFR after orthotopic liver transplantation using cystatin C and creatinine-based equations |
| Q43257947 | Use of the MDRD study equation to estimate kidney function for drug dosing |
| Q34238435 | Warfarin dosing in patients with impaired kidney function |
| Q42165740 | When laboratories report estimated glomerular filtration rates in addition to serum creatinines, nephrology consults increase |